Team

YFountain was founded by biotechnology professor/scientist from The University of California, San Francisco (UCSF). Our professional team include:

Inventors of the innovative, patent pending technology of High-Throughput Screening for Anti-Aging Substances.

Management professional with experiences in biotech research, business finance, administration and compliance.

Pharmaceutical chemist with experiences in translational process, guiding the early stage discoveries through animal tests and clinical trials, and for eventual application in human therapeutic treatments.

Professionals with expertise in artificial intelligence, computational biology and bioinformatics.


	Hao Li, Ph.D. Co-Founder & Patent Inventor Professor, Biochemistry and Biophysics, UCSF Director, Hillblom Center for the Biology of Aging, UCSF Investigator, CZ Biohub Dr. Li received his Ph.D. in theoretical physics from MIT, and has over 20 years of experience leading a research team focusing on bioinformatics, systems biology and aging. Dr. Li developed the first microfluidic system to analyze aging in single cells, and is the primary inventor of the high-throughput microfluidic single-cell analysis chip. Having published ~90 peer reviewed papers, Dr. Li leads research programs supported by NIH, Packard foundation, Hillblom foundation, and CZ Biohub. Dr. Li serves as the advisory board member of Max Planck Society, American Federation for Aging Research, and Member of the Faculty of 1000.
	Changhui Deng, Ph.D. Co-Founder & Patent Inventor Associate Professional Researcher, Biochemistry and Biophysics, UCSF Dr. Deng received his Ph.D. in biochemistry and molecular biology, UC Riverside. An expert in genetics and molecular biology, Dr. Deng developed the daughter arresting program (DAP) that forms the basis of high-throughput screening platform. Dr. Deng has published 13 peer reviewed papers and holds two US patents (pending).
	Yun Bai, Ph.D. Chief Financial Officer Microbiologist Dr. Bai received his Ph. D. from Columbia University in the field of budding yeast research and DNA repair. Besides biological research, Dr. Bai had also worked in the financial industry at Lehman Brothers and JP Morgan Chase, and has a multitude of expertise in biotech research, finance and compliance.
	Michelle Arkin, Ph.D. Scientific Advisor Vice Dean of Research Technology and Entrepreneurship, UCSF Thomas William and Frederick John MacWilliam Distinguished Professor, UCSF Executive Director, Small Molecule Discovery Center (SMDC), UCSF Professor, Department of Pharmaceutical Chemistry, UCSF Dr. Arkin is the Thomas William and Frederick John MacWilliam Distinguished Professor at UCSF. Dr. Arkin serves as the Vice Dean of Research Technology and Entrepreneurship, and the Executive Director of the Small Molecule Discovery Center, a collaborative research and core lab that includes a high-throughput screening facility and medicinal chemistry. Dr. Arkin is a renowned expert on medicinal chemistry, chemical biology, protein-protein interactions, screening, cancer, neurodegenerative disease, and neglected diseases.
	Brian Kennedy, Ph.D. Scientific Advisor Distinguished Professor of Biochemistry & Physiology, Yong Loo Lin School of Medicine, National University of Singapore (NUS) Director, Centre for Healthy Longevity, National University Health System (NUHS) Programme Director, Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, NUS Director, Asian Centre for Reproductive Longevity and Equality, Yong Loo Lin School of Medicine, NUS Adjunct Senior Principal Investigator, Singapore Institute for Clinical Sciences, A*STAR Adjunct Professor, Leonard Davis School of Gerontology, USC, LA, USA Dr. Brian Kennedy is a Distinguished Professor in the Departments of Biochemistry and Physiology at the Yong Loo Lin School of Medicine, National University Singapore. He serves as co-Director of the Centre for Healthy Longevity at the National University Health System and Director for the Healthy Longevity Translational Research Programme and the Asian Centre for Reproductive Longevity and Equality. Prior to that, Dr. Kennedy was the President and CEO of the Buck Institute for Research on Aging. Dr. Kennedy's research seeks to demonstrate that longevity interventions can be successfully employed in humans to extend healthspan, the disease-free and highly functional period of life.